Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00909_DB01319> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00909_DB01319 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00909_DB01319 label "DDI between Zonisamide and Fosamprenavir - Fosamprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zonisamide by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zonisamide if fosamprenavir is initiated, discontinued or dose changed. [drugbank_resource:DB00909_DB01319]" assertion.
- drugbank_resource:DB00909_DB01319 identifier "drugbank_resource:DB00909_DB01319" assertion.
- drugbank_resource:DB00909_DB01319 title "DDI between Zonisamide and Fosamprenavir - Fosamprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zonisamide by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zonisamide if fosamprenavir is initiated, discontinued or dose changed." assertion.